Age-related electrophysiological and histological changes in rabbit hearts: Age-related changes in electrophysiology

International Journal of Cardiology

Volumn 62, Issue 2, 1997, Pages 97-106

  Gottwald, M ^a   Gottwald, E ^a   Dhein, S ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Ageing; Arrhythmia; Cardiac electrophysiology; Epicardial potential mapping; Histology

Indexed keywords

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPICARDIUM; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RABBIT;

AGING; ANIMALS; ATRIOVENTRICULAR NODE; CONNECTIVE TISSUE; ELECTROPHYSIOLOGY; HEART; HEART CONDUCTION SYSTEM; HEART VENTRICLES; HYPERTROPHY; MODELS, THEORETICAL; MYOCARDIUM; ORGAN SIZE; PERICARDIUM; RABBITS; REFERENCE VALUES;

EID: 0031454836     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(97)00183-6     Document Type: Article

References (37)

1. Williams T.F. Demographics of aging. Cardiovasc Clin. 22:1992;3-7.
2. Spach M.S., Dolber P.C. Relating extracellular potentials and their derivates to anisotropic propagation at a microscopic level in human cardiac muscle. Circ Res. 58:1986;356-371.
3. Fleg L.L., Kennedy H.L. Cardiac arrhythmias in a healthy elderly population: Detection by 24-hour ambulatory electrography. Chest. 81:1982;302-307.
4. Gomes J.A., Harimanm R.I., Kang P.S., El-Sherif N., Chowdhry I., Lyons J. Programmed electrical stimulation in patients with high-grade ventricular ectopy: Electrophysiological findings and prognosis for survival. Circulation. 70:1984;43-51.
5. Carbonin P.U., Di Gennaro M., Pahor M., Bernabei R., Sgadari A., Gambassi G. Cardiac aging, calcium overload and arrhythmias. Exp Gerontol. 25:1990;261-268.
6. Kim C.H., Daubert J.P., Akiyama T. Antiarrhythmic agents in older patients, current state of knowledge. Drugs Aging. 4(6):1994;462-469.
7. Dhein S., Müller A., Klaus W. Prearrhythmia: Changes preceding arrhythmia, new aspects by epicardial mapping. Bas Res Cardiol. 85:1990;285-296.
8. Dhein S., Müller A., Klaus W. The potential of epicardial activation mapping in isolated hearts for the assessement of arrhythmogenic and antiarrhythmic drug activity. J Pharmacol Methods. M22:1989;97-206.
9. Dhein S., Müller A., Klaus W. Nifedipine antagonizes ouabain-induced ST-segment changes and derangement of epicardial activation pattern in isolated rabbit hearts. Int J Cardiol. 29:1990;163-172.
10. Langendorff O. Untersuchungen am überlebenden Säugetierherzen. Arch ges Physiol. 61:1895;291-331.
11. Durrer D., Van der Tweel L.H. Spread of activation in the left ventricular wall of the dog. Activation conditions at the epicardial surface. Am Heart J. 47:1954;192-203.
12. Arisi G., Macchi E., Baruffi S., Spaggiari S., Taccardi B. Potential field on the ventricular surface of the exposed dog heart during normal excitation. Circ. Res. 52:1983;706-715.
13. Müller A., Dhein S., Klaus W. Heterogenously distributed sensitivities to potassium as a cause of hypokalemic arrhythmias in isolated rabbit hearts. J Cardiovasc Electrophysiol. 2:1991;145-155.
14. Dhein S., Müller A., Klaus W. Comparative study on the proarrhythmic effects of some antiarrhythmic agents. Circulation. 87:1993;617-630.
15. Millar C.K., Kralios F.A., Lux R.L. Correlation between refractory periods and activation recovery intervals from electrograms: Effects of rate and adrenergic interventions. Circulation. 72:1985;1372-1379.
16. Coronel R. Distribution of extracellular potassium during acute myocardial ischemia. Thesis, Amsterdam, 1988.
17. Romeis B. Mikroskopische Technik. Oldenbourg Verlag, München, Wien, 1968: 176, 174 ff, 275 ff.
18. Schulman SP, Weisfeldt ML. Cardiovascular aging and adaptation to disease. In: Schlant RC, Alexander RW, editors. Hurst's The heart (edition 8). New York: McGraw-Hill Inc., 1994: 2067-2076.
19. Sachs H.G., Colgan J.A., Lazarus M.L. Ultrastructure of the aging myocardium: a morphometric approach. Am J Anat. 150:1977;63-72.
20. Kreher P., Ristori M.T., Corman B., Verdetti J. Effects of chronic angiotensin I-converting enzyme inhibition on the relations between ventricular action potential changes and myocardial hypertrophy in aging rats. J Cardiovasc Pharmacol. 25:1995;75-80.
21. Heins HW. Coronarreserve des menschlichen Herzens. In: Roskamm H, Reindell H, editors. Herzkrankheiten, Pathophysiologie Diagnostik Therapie. Berlin: Springer Verlag, 1982:451-460.
22. Schmidlin O., Bharati S., Lev M., Schwartz J.B. Effect of physiological aging on cardiac electrophysiology in perfused Fischer 344 rat hearts. Am J Physiol. 262:1992;H97-H105.
23. Robinson S. Experimental studies of physical fitness in relation to age. Arbeitsphysiologie. 10:1939;251-323.
24. Brandfonbrener M., Landowne M., Schock M.W. Changes in cardiac output with age. Circulation. 12:1955;557-566.
25. Lüderitz B. Therapie der Herzrhythmusstörungen. Berkun: Springer Verlag, 1993, 3-67.
26. Blümcke S. Altersherz, Herztod, postmortales Herz. In: Blümcke S, editor. Pathologie. Berlin:De Gruyter, 1995: 537.
27. Carbonin P., Cocchi A., Zuccala G., Menichelli P. Heart aging and its clinical implications. Recenti Prog Med. 81(4):1990;215-220.
28. Burgess M.J., Steinhaus B.M., Spiker K.W., Ershler P.R. Nonuniform epicardial activation and repolarization properties of in vivo canine pulmonary conus. Circ Res. 62:1988;233-246.
29. Dhein S., Manicone N., Müller A., Gerwin R., Ziskoven U., Irankhahi A., Minke C., Klaus W. A new synthetic antiarrhythmic peptide reduces dispersion of epicardial activation recovery interval and diminishes alterations of epicardial activation patterns induced by regional ischemia. A mapping study. Naunyn-Schmiedeberg's Arch Pharmacol. 350:1994;174-184.
30. Lazzara R., Scherlag B. Generation of arrhythmias in myocardial ischemia and infarction. Am J Cardiol. 61:1988;20A-26A.
31. Lesh M.D., Pring M., Spear J.F. Cellular uncoupling can unmask dispersion of action potential duration in ventricular myocardiu. Circ Res. 65:1989;1426-1440.
32. Breithardt G, Haverkamp W, Rotman B, Willems S, Hindrick G, Shenasa M, Borggrefe M. Antiarrhythmic drug action, modulation by disease and injury. In: Breithardt G, Borggrefe M, Camm J, Shenasa M, editors. Antiarrhythmic drugs. Berlin:Springer Verlag, 1995: 144-170.
33. Spielman S.R., Schwarz J.S., McCarthy D.M., Horowitz L.N., Greenspan A.M., Sadowski C.M., Josephson M.E., Weyman H.L. Predictors of the success or failure of medical therapy in patients with chronic recurrent sustained ventricular tachycardia: a discriminant analysis. J Am Coll Cardiol. 1:1983;401-408.
34. Anderson Jl. Reassessement of benefit-risk ratio and treatment algorithms for antiarrhythmic drug therapy after the cardiac Arrhythmia Suppression Trial (CAST). J Clin Pharmacol. 30:1990;981-989.
35. Krinsky V.I., Biktashew V.N., Pertsov A.M. Autowave approaches to cessation of reentrant arrhythmias. In: Jalife, editor. Mathematical approaches to cardiac arrhythmia. Ann Ny Acad Sci. 591:1990;232-246.
36. Han J., Moe G.K. Nonuniform recovery of excitability in ventricular muscle. Circ Res. 65:1989;1157-1160.
37. Kuo C.S., Munakata K., Reddy C.P., Surawicz B. Characteristics and possible mechanisms of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation. 67:1983;1356-1367.